CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothblum-Oviatt, C. J.
Right arrow Articles by Piwnica-Worms, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothblum-Oviatt, C. J.
Right arrow Articles by Piwnica-Worms, H.
Cell Growth & Differentiation Vol. 12, 581-589, December 2001
© 2001 American Association for Cancer Research

14-3-3 Binding Regulates Catalytic Activity of Human Wee1 Kinase1

Cynthia J. Rothblum-Oviatt, Christine E. Ryan and Helen Piwnica-Worms2

Department of Cell Biology and Physiology [C. J. R-O., C. E. R., H. P-W.], Department of Internal Medicine [H. P-W.], Howard Hughes Medical Institute [C. E. R., H. P-W.], Washington University School of Medicine, St. Louis, Missouri 63110

The mitotic inducer Cdc2 is negatively regulated, in part, by phosphorylation on tyrosine 15. Human Wee1 is a tyrosine-specific protein kinase that phosphorylates Cdc2 on tyrosine 15. Human Wee1 is subject to multiple levels of regulation including reversible phosphorylation, proteolysis, and protein-protein interactions. Here we have investigated the contributions made by 14-3-3 binding to human Wee1 regulation and function. We report that the interactions of 14-3-3 proteins with human Wee1 are reduced during mitosis and are stable in the presence of the protein kinase inhibitor UCN-01. A mutant of Wee1 that is incapable of binding to 14-3-3 proteins has lower enzymatic activity, and this likely accounts for its reduced potency relative to wild-type Wee1 in inducing a G2 cell cycle delay when overproduced in vivo. These findings indicate that 14-3-3 proteins function as positive regulators of the human Wee1 protein kinase.




This article has been cited by other articles:


Home page
Open BiolHome page
S. I. Freitag, J. Wong, and P. G. Young
Genetic and physical interaction of Ssp1 CaMKK and Rad24 14-3-3 during low pH and osmotic stress in fission yeast
Open Bio, January 1, 2014; 4(1): 130127 - 130127.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
H. T. Ma and R. Y. C. Poon
How protein kinases co-ordinate mitosis in animal cells
Biochem. J., April 1, 2011; 435(1): 17 - 31.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. S. Oh, S. J. Han, and M. Conti
Wee1B, Myt1, and Cdc25 function in distinct compartments of the mouse oocyte to control meiotic resumption
J. Cell Biol., January 25, 2010; 188(2): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Muller, D. Lutter, and A. W. Puschel
Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and SadB-deficient neurons disrupts neuronal polarity
J. Cell Sci., January 15, 2010; 123(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. N. Tse, T. N. Sheikh, H. Alan, T.-C. Chou, and G. K. Schwartz
90-kDa Heat Shock Protein Inhibition Abrogates the Topoisomerase I Poison-Induced G2/M Checkpoint in p53-Null Tumor Cells by Depleting Chk1 and Wee1
Mol. Pharmacol., January 1, 2009; 75(1): 124 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Kamata, N. Watanabe, Y. Nagaoka, and I. S. Y. Chen
Human Immunodeficiency Virus Type 1 Vpr Binds to the N Lobe of the Wee1 Kinase Domain and Enhances Kinase Activity for Cdc2
J. Virol., June 15, 2008; 82(12): 5672 - 5682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna
DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding
Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States
p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Y. Kim, E. J. Song, K.-J. Lee, and J. E. Ferrell Jr.
Multisite M-Phase Phosphorylation of Xenopus Wee1A
Mol. Cell. Biol., December 1, 2005; 25(23): 10580 - 10590.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. S. Stanford and J. V. Ruderman
Changes in Regulatory Phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during Normal Cell Cycle Progression and Checkpoint Arrests
Mol. Biol. Cell, December 1, 2005; 16(12): 5749 - 5760.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Katayama, N. Fujita, and T. Tsuruo
Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M Transition
Mol. Cell. Biol., July 1, 2005; 25(13): 5725 - 5737.
[Abstract] [Full Text] [PDF]


Home page
MCPHome page
A. Benzinger, N. Muster, H. B. Koch, J. R. Yates III, and H. Hermeking
Targeted Proteomic Analysis of 14-3-3{varsigma}, a p53 Effector Commonly Silenced in Cancer
Mol. Cell. Proteomics, June 1, 2005; 4(6): 785 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Yuan, M. Kamata, Y.-M. Xie, and I. S. Y. Chen
Increased Levels of Wee-1 Kinase in G2 Are Necessary for Vpr- and Gamma Irradiation-Induced G2 Arrest
J. Virol., August 1, 2004; 78(15): 8183 - 8190.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. E. M. Meek, W. S. Lane, and H. Piwnica-Worms
Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins
J. Biol. Chem., July 30, 2004; 279(31): 32046 - 32054.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Uchida, A. Kuma, M. Ohtsubo, M. Shimura, M. Hirata, H. Nakagama, T. Matsunaga, Y. Ishizaka, and K. Yamashita
Binding of 14-3-3{beta} but not 14-3-3{sigma} controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B
J. Cell Sci., June 15, 2004; 117(14): 3011 - 3020.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. R. Kellogg
Wee1-dependent mechanisms required for coordination of cell growth and cell division
J. Cell Sci., December 15, 2003; 116(24): 4883 - 4890.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M.-S. Chen, C. E. Ryan, and H. Piwnica-Worms
Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding
Mol. Cell. Biol., November 1, 2003; 23(21): 7488 - 7497.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Matsuo, S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda, and H. Okamura
Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo
Science, October 10, 2003; 302(5643): 255 - 259.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Okubo, J. M. Lehman, and T. D. Friedrich
Negative Regulation of Mitotic Promoting Factor by the Checkpoint Kinase Chk1 in Simian Virus 40 Lytic Infection
J. Virol., January 15, 2003; 77(2): 1257 - 1267.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2001 by the American Association of Cancer Research.